# Oral Wegovy® (Oral Semaglutide) — Imbue Health

> Last updated: 2026-05-27 · Source of truth: https://tryimbue.com/medications/oral-wegovy
> Medically reviewed by the Imbue Health Medical Team

## At a glance

| | |
|---|---|
| **Brand name** | Oral Wegovy® |
| **Generic / active ingredient** | Oral semaglutide (GLP-1 receptor agonist) |
| **Manufacturer** | Novo Nordisk |
| **Fulfilment** | NovoCare (manufacturer pharmacy) |
| **Format** | Once-daily oral pill — empty stomach, ≤120 mL water, 30-minute fast |
| **Cash-pay medication price** | **$149–$299 / month** (by dose) |
| **Total monthly cost on Imbue Health** | **$178–$328 / month** ($29 membership + $149–$299 medication, by dose) |
| **Average weight loss** | 15.1% body weight at 64 weeks (OASIS 1 trial, 50 mg dose) |
| **FDA indication** | Chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥25) with at least one weight-related condition |

### Cash-pay price by dose (Oral Wegovy®)

| Dose | Cash-pay price / month |
|---|---|
| 1.5 mg | $149 |
| 4.0 mg | $149 (limited-time offer; $199 standard) |
| 9 mg | $299 |
| 25 mg | $299 |

Plus a flat $29/month Imbue Health membership. Prices are set by the manufacturer (NovoCare).

## What makes Oral Wegovy® unique

Oral Wegovy® was the **first FDA-approved GLP-1 pill for chronic weight management**. It contains the same active ingredient (semaglutide) as injectable Wegovy® but is taken as a daily tablet instead of a weekly injection.

For patients who want to avoid needles or prefer daily routines over weekly ones, Oral Wegovy® offers the same proven semaglutide pharmacology in pill form — backed by Novo Nordisk's OASIS clinical trial program.

## How to take it

Take Oral Wegovy® **first thing in the morning** on an empty stomach with no more than 4 ounces (120 mL) of plain water. Wait at least **30 minutes** before eating, drinking anything else, or taking other oral medications. Swallow the tablet whole — do not crush, chew, or split it.

This strict protocol is required because semaglutide is a peptide that's normally destroyed by stomach acid. The empty-stomach window ensures the dose absorbs before food disrupts it.

## Clinical results

| Trial | Patients | Result |
|---|---|---|
| **OASIS 1** (Novo Nordisk) | Adults with obesity, 64-week treatment | 15.1% average body-weight loss (50 mg dose) |
| **OASIS program** (cumulative) | Comparable trials | Weight-loss outcomes comparable to injectable semaglutide |

## Side effects

Most common (typically resolve in 2–4 weeks):

- Nausea, vomiting, diarrhoea, constipation
- Decreased appetite
- Headache

Oral-specific side effects:

- Difficulty swallowing
- Gastritis
- Abdominal distension

Boxed warning: thyroid C-cell tumors. Other serious risks: pancreatitis, gallbladder disease, severe GI symptoms, kidney problems. See https://tryimbue.com/safety for complete safety information.

## Eligibility

- Adults 18+ in all 50 U.S. states and Washington, D.C.
- BMI ≥30, **or** BMI ≥25 with at least one weight-related condition.
- BMI 25–26.9 is below FDA label and prescribed at provider discretion.
- No personal or family history of medullary thyroid carcinoma or MEN 2 syndrome.

## How to get Oral Wegovy® through Imbue Health

1. 5-minute health assessment at https://tryimbue.com.
2. Licensed Imbue Health physician evaluation.
3. $29/mo Imbue Health membership.
4. NovoCare ships Oral Wegovy® at $149–$299/month cash-pay (by dose).

**Total: $178–$328/month all-in (by dose).** No insurance, no contracts, cancel anytime.

## Refund policy

If our physician determines Oral Wegovy® isn't right for you, you won't be charged the $29 membership fee.

## FAQ

**Is Oral Wegovy® as effective as injectable Wegovy®?**
Clinical trials show comparable weight-loss outcomes between oral and injectable semaglutide at therapeutic doses. The main difference is the dosing schedule (daily pill vs weekly injection) and the empty-stomach protocol for oral.

**Can I switch from injectable Wegovy® to Oral Wegovy®?**
Yes. Many patients switch to avoid injections. Your Imbue Health provider manages the transition.

**Foundayo™ vs Oral Wegovy® — which is better?**
Both are FDA-approved oral GLP-1s. Foundayo™ (orforglipron, Eli Lilly) can be taken any time of day with no food or water restrictions. Oral Wegovy® (oral semaglutide, Novo Nordisk) requires the empty-stomach protocol but has longer real-world track record and broader insurance coverage in markets that bill insurance. Imbue Health is a cash-pay program so insurance coverage doesn't apply — pick based on convenience preference.

**Why is Oral Wegovy® less expensive than injectable Wegovy®?**
Novo Nordisk sets a lower cash-pay rate for Oral Wegovy® ($149–$299/mo by dose) than for injectable Wegovy® ($199/mo intro, $349–$399/mo standard incl. HD pen). The same molecule, different format, different pricing.

## Related

- Oral vs injectable GLP-1 comparison: https://tryimbue.com/learn/oral-vs-injectable-glp1
- Wegovy® injectable details: https://tryimbue.com/medications/wegovy
- Full GLP-1 guide: https://tryimbue.com/learn/glp1-guide
- Compare all medications: https://tryimbue.com/medications

## About

Operating entity: Cyane Inc. Medical practice: Cyane Medical Group California PC. Medical Director: Dr. Prajeet Reddy, MD. LegitScript Healthcare Merchant Certified. HIPAA-compliant.

Address: 169 Madison Ave Ste 11456, New York, NY 10016 · Phone: +1-855-695-4959 · Email: support@tryimbue.com